These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 15249824

  • 1. Tc-99m DMSA uptake by metastatic colorectal carcinoma.
    Rondogianni P, Koniaris G.
    Clin Nucl Med; 2004 Aug; 29(8):485-7. PubMed ID: 15249824
    [Abstract] [Full Text] [Related]

  • 2. Incidental DTPA and DMSA uptake during renal scanning in unknown bone metastases.
    Balci TA, Ciftci I, Karaoglu A.
    Ann Nucl Med; 2006 Jun; 20(5):365-9. PubMed ID: 16878710
    [Abstract] [Full Text] [Related]

  • 3. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy.
    Yüksel D, Ilgan S, Arslan N, Uğur O, Oztürk E, Bayhan H.
    Clin Nucl Med; 2000 Mar; 25(3):193-6. PubMed ID: 10698416
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions.
    Sahin M, Basoglu T, Bernay I, Yapici O, Canbaz F, Yalin T.
    Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327
    [Abstract] [Full Text] [Related]

  • 5. Bone metastases demonstrated by pentavalent Tc-99m DMSA and Tc-99m HMDP.
    Hirano T, Otake H.
    Clin Nucl Med; 1997 Sep; 22(9):640-1. PubMed ID: 9298304
    [No Abstract] [Full Text] [Related]

  • 6. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
    Yen TC, King KL, Yang AH, Liu RS, Yeh SH.
    J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy.
    Kobayashi H, Kotoura Y, Hosono M, Sakahara H, Hosono M, Yao ZS, Tsuboyama T, Yamamuro T, Endo K, Konishi J.
    Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996
    [Abstract] [Full Text] [Related]

  • 8. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
    Kashyap R, Babbar A, Sahai I, Prakash R, Soni NL, Chauhan UP.
    Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the use of technetium Tc 99m diethylenetriamine pentaacetic acid and technetium Tc 99m dimercaptosuccinic acid for scintigraphic imaging of the kidneys in green iguanas (Iguana iguana).
    Greer LL, Daniel GB, Shearn-Bochsler VI, Ramsay EC.
    Am J Vet Res; 2005 Jan; 66(1):87-92. PubMed ID: 15691041
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers.
    Atasever T, Gündoğdu C, Vural G, Kapucu LO, Karalezli A, Unlü M.
    Nuklearmedizin; 1997 Oct; 36(7):223-7. PubMed ID: 9394361
    [Abstract] [Full Text] [Related]

  • 11. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
    Wulfrank DA, Schelstraete KH, Small F, Fallais CJ.
    Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
    [Abstract] [Full Text] [Related]

  • 12. Pentavalent technetium-99m DMSA uptake in pseudofractures of osteomalacia.
    Sahin M, Basoglu T, Albayrak S, Canbaz F, Yapici O.
    Clin Nucl Med; 2001 Jan; 26(1):62-4. PubMed ID: 11139060
    [Abstract] [Full Text] [Related]

  • 13. Technetium-99m DMSA abnormal uptake by metastatic lesion of a renal cell carcinoma.
    Kosuda S, Hirono Y, Yoshinaga H, Saito K, Tamura K, Kubo A, Hashimoto S.
    Clin Nucl Med; 1986 Jun; 11(6):432-3. PubMed ID: 3013485
    [No Abstract] [Full Text] [Related]

  • 14. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
    Ohnishi T, Noguchi S, Murakami N, Tajiri J, Morita M, Tamaru M, Hoshi H, Watanabe K.
    J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
    [Abstract] [Full Text] [Related]

  • 15. Localization of accessory renal artery infarction using Tc-99m DMSA scintigraphy.
    Dirlik A, Ozbek SS, Toz H, Hoscoskun C, Ozcan Z.
    Clin Nucl Med; 2004 Oct; 29(10):649-51. PubMed ID: 15365444
    [No Abstract] [Full Text] [Related]

  • 16. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
    Ergün EL, Kara PO, Gedik GK, Kars A, Türker A, Caner B.
    Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
    Ohta H, Ishii M, Yoshizumi M, Endo K, Sakahara H, Nakajima T, Yomoda I, Masuda H, Horiuchi K, Hata N.
    Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
    [Abstract] [Full Text] [Related]

  • 18. Tc-99m DMSA uptake by metastatic carcinoma of the prostate.
    Lamki L, Shearer R.
    J Nucl Med; 1984 Jun; 25(6):733-4. PubMed ID: 6327947
    [No Abstract] [Full Text] [Related]

  • 19. Technetium-99m-dimercaptosuccinic acid renal scintigraphy can guide clinical management in congenital hydronephrosis.
    Bazić-Đorović B, Radulović M, Šišić M, Jauković L, Dugonjić S, Pucar D, Janković Z, Beatović S, Janković M, Krstić Z, Ajdinović B.
    Hell J Nucl Med; 2017 Jun; 20 Suppl():114-122. PubMed ID: 29324920
    [Abstract] [Full Text] [Related]

  • 20. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.
    Kao CH, Wang SJ, Wey SP, Shen LH, Ting G, Yeh SH.
    Eur J Nucl Med; 1992 Jun; 19(10):890-3. PubMed ID: 1333404
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.